Postoperative Concomitant Chemoradiotherapy Improved Treatment Outcomes of Patients with Oral Cavity Cancer with Multiple-Node Metastases but No Other Major Risk Factors

Documenti analoghi

• Postoperative concomitant chemoradiotherapy improved treatment outcomes of patients with oral cavity cancer with multiple-node metastases but no other major risk factors.
  di: Kang-Hsing Fan, et al.
  Pubblicazione: (2014-01-01)
• The comparison between weekly and three-weekly cisplatin delivered concurrently with radiotherapy for patients with postoperative high-risk squamous cell carcinoma of the oral cavity
  di: Tsan, Din-Li, et al.
  Pubblicazione: (2012)
• Human Papillomavirus-16 Infection in Advanced Oral Cavity Cancer Patients Is Related to an Increased Risk of Distant Metastases and Poor Survival
  di: Lee, Li-Ang, et al.
  Pubblicazione: (2012)
• Postoperative radiotherapy with or without concurrent chemotherapy for oral squamous cell carcinoma in patients with three or more minor risk factors: a propensity score matching analysis
  di: Fan, Kang-Hsing, et al.
  Pubblicazione: (2017)
• A phase II randomized trial comparing neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in advanced squamous cell carcinoma of the pharynx or larynx
  di: Huang, Pei-Wei, et al.
  Pubblicazione: (2018)